Viewing Study NCT01009203

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2026-05-01 @ 11:29 PM
Study NCT ID: NCT01009203
Status: TERMINATED
Last Update Posted: 2015-08-10
First Post: 2009-11-05
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
Sponsor: New Mexico Cancer Research Alliance
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None squamous cell carcinoma View
None head View
None neck View
None aerodigestive View